DNA mismatch repair (MMR)‐dependent 5‐fluorouracil cytotoxicity and the potential for new therapeutic targets
- 14 October 2009
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 158 (3) , 679-692
Abstract
The metabolism and efficacy of 5‐fluorouracil (FUra) and other fluorinated pyrimidine (FP) derivatives have been intensively investigated for over fifty years. FUra and its antimetabolites can be incorporated at RNA‐ and DNA‐levels, with RNA level incorporation provoking toxic responses in human normal tissue, and DNA‐level antimetabolite formation and incorporation believed primarily responsible for tumour‐selective responses. Attempts to direct FUra into DNA‐level antimetabolites, based on mechanism‐of‐action studies, have led to gradual improvements in tumour therapy. These include the use of leukovorin to stabilize the inhibitory thymidylate synthase‐5‐fluoro‐2′‐deoxyuridine 5′ monophoshate (FdUMP)‐5,10‐methylene tetrahydrofolate (5,10‐CH2FH4) trimeric complex. FUra incorporated into DNA also contributes to antitumour activity in preclinical and clinical studies. This review examines our current state of knowledge regarding the mechanistic aspects of FUra:Gua lesion detection by DNA mismatch repair (MMR) machinery that ultimately results in lethality. MMR‐dependent direct cell death signalling or futile cycle responses will be discussed. As 10–30% of sporadic colon and endometrial tumours display MMR defects as a result of human MutL homologue‐1 (hMLH1) promoter hypermethylation, we discuss the use and manipulation of the hypomethylating agent, 5‐fluorodeoxycytidine (FdCyd), and our ability to manipulate its metabolism using the cytidine or deoxycytidylate (dCMP) deaminase inhibitors, tetrahydrouridine or deoxytetrahydrouridine, respectively, as a method for re‐expression of hMLH1 and re‐sensitization of tumours to FP therapy.Keywords
This publication has 135 references indexed in Scilit:
- Sequence context effect for hMSH2-hMSH6 mismatch-dependent activationProceedings of the National Academy of Sciences, 2009
- DNA Mismatch Repair-dependent Activation of c-Abl/p73α/GADD45α-mediated ApoptosisJournal of Biological Chemistry, 2008
- Role of c-Abl Kinase in DNA Mismatch Repair-dependent G2 Cell Cycle Checkpoint Arrest ResponsesJournal of Biological Chemistry, 2008
- Coupling distant sites in DNA during DNA mismatch repairProceedings of the National Academy of Sciences, 2007
- Protein roadblocks and helix discontinuities are barriers to the initiation of mismatch repairProceedings of the National Academy of Sciences, 2007
- ATR Kinase Activation Mediated by MutSα and MutLα in Response to Cytotoxic O6-Methylguanine AdductsMolecular Cell, 2006
- Gene conversion in Escherichia coliJournal of Molecular Biology, 1986
- Mutagen-induced changes in cellular deoxycytidine triphosphate and thymidine triphosphate in Chinese hamster ovary cellsBiochemical and Biophysical Research Communications, 1983
- Rapid changes in deoxynucleoside triphosphate pools in mammalian cells treated with mutagensBiochemical and Biophysical Research Communications, 1983
- Bromouracil mutagenesis and mismatch repair in mutator strains of Escherichia coliMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1978